Login
Enter your username or email address
Enter the password that accompanies your username.

Request new password

Site Branding logo

Progress in Mind Canada

  • About
  • Topics
    • Bipolar disorder
    • Depression
    • Schizophrenia
    • Migraine
  • Canadian congress highlights
    • English
    • French

Canadian psychiatry & neurology congress highlights

Updates on trending topics in depression, migraine, schizophrenia and bipolar disorder

  • Depression 21 May, 2025 Read Time: 4 mins
    Congress highlights Article

    Biomarkers: Towards personalized treatment of MDD

    Predictive biomarkers for guiding antidepressant treatment selection could be an important tool for...
  • Migraine 12 Nov, 2024 Read Time: 3 mins
    Congress highlights Article

    New Canadian Headache Society guideline for migraine prophylaxis

    The Canadian Headache Society (CHS) presented its updated migraine prophylaxis guideline at the World...
  • Depression 22 Oct, 2024 Read Time: 3 mins
    Congress highlights Article

    Biomarkers for Early Depression: More Than Meets the Eye

    Early recognition and treatment of major depressive disorder (MDD) is recognized as an important...
  • Mental Health 01 Oct, 2024 Read Time: 3 mins
    Congress highlights Article

    Is TikTok fueling self diagnosis of mental disorders?

    Social media platforms such as TikTok have seen a steep rise in use in recent years, particularly...
  • Migraine 15 Aug, 2024 Read Time: 4 mins
    Congress highlights Article

    Getting Ahead of Migraine – Multidisciplinary strategies for improving patient outcomes

    At the 2024 Canadian Neurological Sciences Federation congress, Dr. William Kingston (Sunnybrook...
  • Bipolar 12 Aug, 2024 Read Time: 4 mins
    Congress highlights Article

    How a detective mindset can optimize the approach to dual substance use and bipolar disorders

    Substance use disorders (SUD) are common in patients with bipolar disorder, but they complicate the...
  • Depression 05 Aug, 2024 Read Time: 4 mins
    Congress highlights Article

    Psychedelic-Assisted Therapy: A New Tool for Refractory Psychiatric Illness?

    Psychedelics are widely known as recreational drugs of abuse, but they have been used in medical...
  • PTSD, Depression 15 Jul, 2024 Read Time: 3 mins
    Congress highlights Article

    The Ottawa Anxiety Algorithm: A Point of Care Tool for Primary Care

    Anxiety disorders are the most common psychiatric disorder seen in primary care, yet evidence...
  • Load More

Most Popular

Depression
21 Jan, 2025

Neurobiology and Therapeutic Approaches to Anhedonia in MDD

Migraine 15 Jan, 2025
Exploring migraine biochemistry for novel drug target discovery
Migraine 23 Apr, 2025
Structural and functional brain changes in anti-CGRP treatment responders
Depression 21 May, 2025
Biomarkers: Towards personalized treatment of MDD

PROGRESS IN MIND RESOURCE CENTRE CANADA

HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Canada click here.

Your privacy is important. When you register, we may collect your personal information such as your name and contact details, as outlined at 'Lundbeck and Privacy’ on our Progress in Mind website.

Register Already registered

BROUGHT TO YOU BY

Lundbeck
© 2022 Lundbeck Canada

PROGRESS IN MIND CANADA

Lundbeck and Privacy

Contact us

Terms and Conditions

Cookies

Lundbeck Canada INC.

2600 Alfred-Nobel boulevard

Suite 400

Saint-Laurent

H4S 0A9 Montréal Québec

Canada

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue

By submitting this form you agree that your email is sent to a third party for validation.

Read the full terms and conditions here.